Clearing the US and EU Regulatory Path to Product Approval – “What Similarities and Differences Exist and How Can Companies Manage the Hurdles?”

Learn how to navigate through the complexities and policy changes that biotech and nanotech products face today. Expert advice and case studies will provide valuable lessons on how policy and regulation is influencing technology in the US and EU and what companies can do to save time and cost throughout the process. Do regulatory agencies have the legal authority to make judgments on nanomaterials? Are they ready for this responsibility?

FAO FOOD NANOTECHNOLOGY COMPANIES
PhD student seeks funding for COMS 2008 CONFERENCE FOOD AND DRINKS SESSION
The talk and paper provides an understanding of the magnitude of the problem of diet induced disease. The primary objective is to provide information on how food nanotechnology has the potential to help prevent the diet induced diseases of civilization. To achieve that future potential, food nanotechnologists must look beyond the status quo e.g. medical efforts focusing more on treatments for older people than on preventing primary causes of diet induced disease in young people and understand causal mechanisms of disease. In order to fully understand how consuming novel Neolithic and Industrial Era foods may currently predispose people to chronic disease, the review begins with a look back at our past diet and its importance as a fuel supply for the brain